Type 2 diabetes
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: <Type 2 diabetes group> Hospitalized Patients with type 2 diabetes who fulfilled the following criteria. 1) Age is over 20 and below 70. 2) Patients diagnosed with type 2 diabetes. 3) Having provided voluntary written consent for participation in this study. <Control group> Hospitalized Patients with non-type 2 diabetes who fulfilled the following criteria. 1) Age is over 20 and below 70. 2) Patients who are not diagnosed with type 2 diabetes. 3) Having provided voluntary written consent for participation in this study.
Exclusion criteria
Exclusion criteria: Patients corresponding to any of the following are inapplicable <Type 2 diabetes group> 1)Patients with severe complications( liver disease, mental disorder, cancer) 2)Patients with severe ketosis or diabetic coma. 3)Patients with severe infections, perioperative status, or severe trauma 4) Patients whose baseline eGFR were <29 ml/min/1.73m^2 5)Pregnancy or lactation in women 6) Patients who are judged by an investigator to be inappropriate for this study for any other reason. <Control group> 1)Patients with severe complications( liver disease, mental disorder, cancer) 2)Patients with severe infections, perioperative status, or severe trauma 3)Pregnancy or lactation in women 4) Patients who are judged by an investigator to be inappropriate for this study for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Serpina3 / EGFR / Adipsin levels | — |
Secondary
| Measure | Time frame |
|---|---|
| The association of the serum Serpina3 / EGFR / Adipsin levels with the various metabolic parameters is analyzed in enrolled subjects. | — |
Countries
Japan
Contacts
Yokohama City University Graduate School of Medicine Department of Endocrinology and Metabolism